fomesafen has been researched along with Long QT Syndrome 1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almatlouh, K; Bundgaard, H; Christensen, AH; Graff, C; Kanters, JK; Marstrand, P; Theilade, J | 1 |
1 trial(s) available for fomesafen and Long QT Syndrome 1
| Article | Year |
|---|---|
Long QT syndrome type 1 and 2 patients respond differently to arrhythmic triggers: The TriQarr in vivo study.
Topics: Acoustic Stimulation; Adrenergic beta-Antagonists; Adult; Diving Reflex; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Male; Reflex; Romano-Ward Syndrome | 2021 |